Eikon Therapeutics Inc. (EIKN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
4:18 pm
Purchase
2026-03-3113GEIKON THERAPEUTICS INC
EIKN
Innovation Endeavors III LP2,723,226
5.000%
2,723,226increase
(New Position)
Filing
History
2026-05-13
5:24 pm
Purchase
2026-02-0413GEIKON THERAPEUTICS INC
EIKN
PERLMUTTER ROGER M2,893,171
5.200%
2,893,171increase
(New Position)
Filing
History
2026-05-06
11:13 am
Purchase
2026-03-3113GEIKON THERAPEUTICS INC
EIKN
FMR LLC3,836,830
7.100%
3,836,830increase
(New Position)
Filing
History
2026-04-29
4:08 pm
Purchase
2026-03-3113GEIKON THERAPEUTICS INC
EIKN
BlackRock Portfolio Management LLC3,002,737
5.500%
3,002,737increase
(New Position)
Filing
History
2026-02-18
4:16 pm
Purchase
2026-02-0413GEIKON THERAPEUTICS INC
EIKN
Abu Dhabi Investment Authority2,816,714
5.200%
2,816,714increase
(New Position)
Filing
History
2026-02-12
6:48 pm
Purchase
2026-02-0613DSURROZEN INC
SRZN
The Column Group IV GP, LP6,353,712
11.600%
6,353,712increase
(New Position)
Filing
History
2026-02-11
4:08 pm
Purchase
2026-02-0413GEIKON THERAPEUTICS INC
EIKN
Foresite Capital Fund IV, L.P.4,148,519
7.700%
4,148,519increase
(New Position)
Filing
History